Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 11, 2005, Pages 4778-4780

  Xie, Zhifang ^a   Siddiqi, Noman ^a   Rubin, Eric J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIMYCOBACTERIAL AGENT; APRAMYCIN; CAPREOMYCIN; CHLORPROMAZINE; CYCLOSERINE; DAPSONE; ERYTHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PHENOTHIAZINE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN SULFATE; TETRACYCLINE; THIOACETAZONE; TRIFLUOPERAZINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STARVATION;

ANTI-BACTERIAL AGENTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHENOTHIAZINES;

EID: 27644588268     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.11.4778-4780.2005     Document Type: Article

References (16)

1. Amaral, L., J. E. Kristiansen, L. S. Abebe, and W. Millett. 1996. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J. Antimicrob. Chemother. 38:1049-1053.
2. Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-731.
3. Boshoff, H. I., T. G. Myers, B. R. Copp, M. R. McNeil, M. A. Wilson, and C. E. Barry III. 2004. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279:40174-40184.
4. Burman, W. J. 1997. The value of in vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: a critical review. Am. J. Med. Sci. 313:355-363.
5. Chuard, C., P. E. Vaudaux, R. A. Proctor, and D. P. Lew. 1997. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J. Antimicrob. Chemother. 39:603-608.
6. Eng, R. H. K., F. T. Padberg, S. M. Smith, E. N. Tan, and C. E. Cherubin. 1991. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob. Agents Chemother. 35:1824-1828.
7. Giard, J. C., A. Hartke, S. Flahaut, A. Benachour, P. Boutibonnes, and Y. Auffray. 1996. Starvation-induced multiresistance in Enterococcus faecalis JH2-2. Curr. Microbiol. 32:264-271.
8. Gomez, J. E., and J. D. McKinney. 2004. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinburgh) 84:29-44.
9. Heifets, L., J. Simon, and V. Pham. 2005. Capreomycin is active against non-replicating M. tuberculosis. Ann. Clin. Microbiol. Antimicrob. 4:6.
10. Herbert, K. C., and S. J. Foster. 2001. Starvation survival in Listeria monocytogenes: characterization of the response and the role of known and novel components. Microbiology 147:2275-2284.
11. S) independent and occurs through both phoP-dependent and -independent pathways. J. Bacteriol. 178:3683-3688.
12. Millar, M. R., and J. Pike. 1992. Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori. Antimicrob. Agents Chemother. 36:185-187.
13. Ordway, D., M. Viveiros, C. Leandro, R. Bettencourt, J. Almeida, M. Martins, J. E. Kristiansen, J. Molnar, and L. Amaral. 2003. Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:917-922.
14. Tuomanen, E., and A. Tomasz. 1990. Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics. Scand. J. Infect. Dis. Suppl. 74:102-112.
15. Wallis, R. S., S. Patil, S.-H. Cheon, K. Edmonds, M. Phillips, M. D. Perkins, M. Joloba, A. Namale, J. L. Johnson, L. Teixeira, R. Dietze, S. Siddiqi, R. D. Mugerwa, K. Eisenach, and J. J. Ellner. 1999. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:2600-2606.
16. Weinstein, E. A., T. Yano, L. S. Li, D. Avarbock, A. Avarbock, D. Helm, A. A. McColm, K. Duncan, J. T. Lonsdale, and H. Rubin. 2005. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proc. Natl. Acad. Sci. USA 102:4548-4553.